Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px
All >

Deals > Austria

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria or involving Austrian organisations.

Total search results: 256 | Ordered by Date (descending)
1 2 3  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Qiagen–Curetis: bioinformatics, 201902– license excl to use ARESdb for general bioinformatics research offerings + services for AMR research 2019-02-18
Link Health–Marinomed: drug delivery technology, 201901– collab registration + distribution of Marinosolv products in China by Link Health 2019-01-21
Curetis–Vienna (govt): grant, 201901–202106 co-funding of developm project of Ares Genetics for AMR assay by Vienna Business Agency 2019-01-01
Marinomed–EU (govt): credit, 20901–2027 up to €15m EIB credit 2019–2022 repayable 2024–2027 2019-01-01
Novartis–Curetis: antibiotics research, 201812– collab Sandoz to use Ares Genetics’ antibiotic resistance database ARESdb 2018-12-18
Imprint Analytics–SGS: credit, 201812– convertible loan as part of strategic partnership 2018-12-12
SGS–Imprint Analytics: food analysis, 201812– collab strategic partnership isotope analysis for proof of origin + authenticity food testing 2018-12-12
F2G Ltd–EU (govt): credit, 201811– InnovFin €24m loan from EIB to F2G Biotech GmbH for antifungals r+d 2018-11-22
Alicona–Bruker Corp: investment, 201811–201812 acquisition €na of Alicona Imaging GmbH by Bruker 2018-11-14
Marinomed–SEVERAL: investment, 201811–201901 IPO €19.5m+€2.925m with 260k+39k new bearer shares at €75/share 2018-11-05
VTU–KonValue: investment, 201810 acquisition of VTU Technology by KonValue Group from VTU Holding GmbH + renaming as Validogen GmbH 2018-10-22
Univ Salzburg–Thermo Fisher: mass spectrometry, 201809 collab biopharma characterisation with LC-MS with CDL at Univ Salzburg 2018-09-20
PhagoMed–Austria (govt): grant, 201808–2021 research project grant €3.5m from FFG 2018-08-28
PhagoMed–Austria (govt): investment, 201808 seed financing round totalling €1.55m incl €800k aws-Seedfinancing 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round totalling €1.55m incl €750k from private investors 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round €1.55m from private investors + aws 2018-08-28
Bayer–Haplogen: antiviral agents, 201808– collab €na developm candidates for pulmonary diseases incl COPD 2018-08-14
Biocrates–MC Services: public relations, 201807 service existent by MC Services 2018-07-25
Agilent–AMETEK: FTIR analyzer, 201807 collab developm + manufacturing Miniscan IR LOG FTIR analyzer for in-field oil/grease analysis 2018-07-18
Gilead–Hookipa: therapeutic vaccine technology, 201806– collab + license $10m upfront r+d immunotherapies against HIV + HBV 2018-06-05
Biovertis–Deinove: investment, 201804–201805 acquisition of Biovertis/Morphochem for €900k in 500k new shares + 8m warrants 2018-04-13
Hookipa–Cowen: investor conference, 201803 supply service Hookipa presents at Cowen & Co Annual Health Care Conference 2018 2018-03-12
Medical Univ Vienna–bio.logis: genetic software, 201803 collab use of bio.logis GIMS.DRM with safety code card at MUW 2018-03-12
Affiris–PR&D: public relations, 201803 service existent by PR&D – Public Relations for Research & Education 2018-03-01
Hookipa–Leerink: investor conference, 201802 supply service Hookipa to attend Leerink Partners Global Healthcare Conference 2018 2018-02-14
REPO-TRIAL project–Biocrates: drug respositioning, 201802–202301 collab Biocrates is industry member of Horizon 2020 project 2018-02-01
REPO-TRIAL project–HM Pharma Consultancy: drug respositioning, 201802–202301 collab HMPC is industry member of Horizon 2020 project 2018-02-01
Cellnovo–Flextronics: contract manufacturing, 201801 supply existent production of Cellnovo Diabetes Monitoring System + Cartridges by Flex 2018-01-17
Hookipa–JPMorgan Chase: investor conference, 201801 supply service Hookipa presents at JP Morgan Healthcare Conference 2018 2018-01-08
Themis Bioscience–SEVERAL: investment, 201801 financing round Series C €10m led by new investor GHIF 2018-01-04
Themis Bioscience–Trophic Communications: public relations, 201801 service existent by Trophic 2018-01-04
BASF–Biocrates: investment, 201801 acquisition of Metanomics Health GmbH by Biocrates from BASF Plant Science GmbH 2018-01-03
Biocrates–BASF: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
Biocrates–MIG Fonds: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
Biocrates–SEVERAL: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
Biocrates–Xolaris Service KVG: investment, 201801 financing round incl BASF Plant Science GmbH + MIG Fonds + GA Asset Fund 2018-01-03
Hookipa–BioMedPartners: investment, 201712 financing round Series C totalling €50m incl returning investor BioMedPartners 2017-12-11
Hookipa–Boehringer: investment, 201712 financing round Series C totalling €50m incl returning investor BIVF 2017-12-11
Hookipa–Forbion: investment, 201712 financing round Series C totalling €50m incl returning investor Forbion Capital Partners 2017-12-11
Hookipa–Gilead: investment, 201712 financing round Series C totalling €50m incl new + strategic investor Gilead 2017-12-11
Hookipa–HBM: investment, 201712 financing round Series C totalling €50m incl new investor HBM Partners 2017-12-11
Hookipa–Hillhouse Capital: investment, 201712 financing round Series C totalling €50m incl new investor Hillhouse Capital 2017-12-11
Hookipa–OTHER: investment, 201712 financing round Series C totalling €50m incl undisclosed US public investment fund as new + lead investor 2017-12-11
Hookipa–SEVERAL: investment, 201712 financing round Series C €50m led by undisclosed US public investment fund 2017-12-11
Hookipa–Sirona Capital: investment, 201712 financing round Series C totalling €50m incl new investor Sirona Capital 2017-12-11
Hookipa–Sofinnova: investment, 201712 financing round Series C totalling €50m incl returning investor Sofinnova Partners 2017-12-11
Hookipa–Takeda: investment, 201712 financing round Series C totalling €50m incl returning investor Takeda Ventures 2017-12-11
Apeiron–MC Services: public relations, 201710 service existent by MC Services AG 2017-10-13
BIA Separations–Nuvonis: vaccine + gene therapy production technology, 201710– collab co-marketing of cell lines + purification technologies 2017-10-10
Medical Univ Innsbruck–Helmholtz: IP services, 201710– service collab knowledge + technology transfer with Ascenion GmbH 2017-10-09
Boehringer–Allcyte: drug discovery, 201709– collab using Pharmacoscopy ex vivo drug response profiling platform for BI oncology candidates 2017-09-04
Apeiron–EU (govt): credit, 201708– EIB EFSI loan €25m to support developm of cancer drugs 2017-08-28
mySugr–Roche: investment, 201706 acquisition of remaining shares by Roche 2017-06-30
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201706– collab co-marketing of new AbsoluteIDQ p400 HR Kit with Q Exactive HRAM MS systems 2017-06-05
ViraTherapeutics–MC Services: public relations, 201705 service existent by MC Services 2017-05-30
Hookipa–Instinctif Partners: public relations, 201704 service existent by Instinctif Partners 2017-04-19
Nabriva–Ally Bridge Group: investment, 201702 investment €na by ABG 2017-02-23
AudioCure Pharma–MED-EL: investment, 201611 financing round totalling €9m from new investor MED-EL + HTGF + private investors 2016-11-29
Themis Bioscience–SEVERAL: investment, 201611 financing round Series B €10m 2nd + final closing with additional €3m 2016-11-28
Hookipa–Austria (govt): grant, 201610 5th FFG grant €4.16m to develop arenavirus vector-based cancer immunotherapies 2016-10-17
Boehringer–ViraTherapeutics: cancer immunotherapy, 201609– long-term collab up to €210m to develop oncolytic virus platform + products 2016-09-28
ViraTherapeutics–Boehringer: investment, 201809 acquisition of all remaining shares of ViraTby BI with total transaction value of €210m 2016-08-01
Sony–Stratec: investment, 201606–201607 acquisition €30m 100% of Sony DADC BioSciences business by Stratec 2016-06-08
Boehringer–VTU: recombinant protein production, 201604– collab ww expansion of agreem for Pichia pastoris technology + incl E coli platform 2016-04-27
Minapharm–Eucodis: ADC technology, 201604– license excl for C-LiNK (CTAT) technology to ProBioGen 2016-04-19
Greiner–Oncgnostics: cervical cancer test, 201511– distribution of GynTect test by Greiner Bio-One in DACH + FR + GB + Benelux 2015-11-18
Greiner–Scienion: print/spotting technology, 201511 collab integrating sciFlexarrayer techn w Genspeed platform for rapid Dx tests 2015-11-13
Marinomed–Austria (govt): investment, 201510 aws Mittelstandsfonds aquires share in Marinomed 2015-10-06
Fianostics–Sony: fluorescence immunoassay platform, 201510– collab contract manufacturing for MEF assay platform by Sony DADC BioSciences 2015-10-05
Nabriva–SEVERAL: investment, 201509 US IPO $92.25m with 9m ADSs at $10.25/ADS at Nasdaq 2015-09-23
Sanofi–Apeiron: cancer immunotherapy, 201508– collab r+d small-molecules of Evotec + Apeiron + Sanofi 2015-08-10
Anagnostics–Cube Dx: investment, 201507 acquisition of all assets of Anagnostics Bioanalysis GmbH by Cube Dx GmbH 2015-07-21
TAmiRNA–EU (govt): grant, 201507– Horizon 2020 SME Instrument Phase I Funding for collab with IPF Vienna 2015-07-01
ViraTherapeutics–Austria (govt): investment, 201506 financing round Series A 1st closing totalling €3.6m incl co-investor aws 2015-06-23
ViraTherapeutics–Boehringer: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
ViraTherapeutics–EMBL: investment, 201506 financing round Series A 1st closing totalling €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
ViraTherapeutics–SEVERAL: investment, 201506 financing round Series A 1st closing €3.6m co-led by BIVF + EMBL Ventures 2015-06-23
Affiris–MIG Fonds: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
Affiris–SEVERAL: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
Affiris–Strüngmann Group: investment, 201506 financing round €10m equally subscribed by major investors Santo Holding + MIG Funds 2015-06-16
BIA Separations–Labena: investment, 201506 acquisition of BIA Separation’s CRO laboratory by Labena 2015-06-08
Labena–BIA Separations: chromatography column, 201506– distribution of CIM columns by Labena in South Eastern Europe 2015-06-08
Biomay–VTU: recombinant protein production, 201505– license to Pichia pastoris protein expression technology to produce rec allergens 2015-05-20
Medigene–Informa: investor conference, 201505 supply service Medigene participant at BioEquity Europe 2015 in Vienna 2015-05-19
Medi Analytika India–BIA Separations: chromatography, 201505– distribution of CIM monolyth columns in India by Medi Analytika 2015-05-15
Themis Bioscience–Omnes Capital: investment, 201505 financing round Series B 1st closing totalling €7m incl existing investor Omnes 2015-05-05
Themis Bioscience–SEVERAL: investment, 201505 financing round Series B €10m 1st closing €7m led by Wellington Partners 2015-05-05
Themis Bioscience–Ventech: investment, 201505 financing round Series B 1st closing totalling €7m incl existing investor Ventech 2015-05-05
Themis Bioscience–Wellington Partners: investment, 201505 financing round Series B 1st closing totalling €7m incl new + led investor Wellington 2015-05-05
Cyclenium–Haplogen: virostatic agents, 201505– collab drug discovery small molecule macroycle inhibitors using CMRT technology 2015-05-01
Nabriva–SEVERAL: investment, 201504 financing round Series B 1st tranche $50m of total $120m Series B led by Vivo Capital + OrbiMed 2015-04-07
Hichrom–BIA Separations: chromatography, 201504– distribution of CIM monolyth columns in UK by Hichrom Ltd 2015-04-06
Ionicon–Tofwerk: mass spectrometer, 201503 supply existent OEM of ToF MS systems for Ionicon products 2015-03-03
NUA GmbH–Eurofins: investment, 201503 acquisition by Eurofins 2015-03-01
Boehringer–VTU: recombinant protein production, 201502– collab ww renewal of agreem for Pichia pastoris technology 2015-02-10
Haplogen–Horizon Discovery: investment, 201501 acquisition of Haplogen Genomics GmbH for upfront €3.8m cash + €3.8m shares + €5m milestones in shares 2015-01-08
Miracor–SEVERAL: investment, 201501 financing round Series B extension €4.5m from BioMedInvest + AWS + SHS + Earlybird + Delta Partners 2015-01-08
ViraTherapeutics–Austria (govt): investment, 2015c financing €1.6m from FFG + aws seed financing programme 2015-01-01
Dutalys–Roche: investment, 201412 acquisition $133.75m upfront cash + $355m milestones 2014-12-18
VBC-Biotech–Eurofins: investment, 201410 acquisition merger establishing Eurofins Genomics AT GmbH taking over VBC services 2014-10-21
1 2 3  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top